Mark N. Tompkins - 01 Nov 2024 Form 4 Insider Report for Lomond Therapeutics Holdings, Inc.

Role: Former Director
Signature: /s/ Mark N. Tompkins
Issuer symbol: N/A
Transactions as of: 01 Nov 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Nov 2024, 18:35:40 UTC
Previous filing: 02 Aug 2023
Next filing: 31 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction		Common Stock	Other	$0	-3,550,000	-75%	$0.000000	1,200,000	01 Nov 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mark N. Tompkins is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 3,550,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director of the Issuer upon consummation of the Merger.

Content

As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 3,550,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director of the Issuer upon consummation of the Merger.